FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to experimental cardiology and pharmacology, and concerns correction of endothelial dysfunction. That is ensured by administering a mixture of solutions of homoeopathic dilutions of monoclonal antibodies to interleukin-1 intragastrically into Wistar white male rats 2 times a day in a dose of 4.5 mg/kg for 28 days with underlying intraperitoneal administration of L-NAME in a dose of 12.5 mg/kg a day.
EFFECT: administering homoeopathic dilutions of monoclonal antibodies to interleukin-1 prevents developing L-NAME induced endothelial dysfunction.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF INTERLEUKIN-6 ANTIBODIES | 2011 |
|
RU2477530C2 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIBODIES | 2011 |
|
RU2526151C2 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE ANTIBODIES | 2011 |
|
RU2477529C2 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF HUMAN ENDOTHELIAL NITROGEN OXIDE SYNTHASE ANTIBODIES IN COMPLEX WITH SOLUTION OF HOMOEOPATHIC DILUTIONS OF ANGIOTENSIN II RECEPTOR C-TERMINAL FRAGMENT ANTIBODIES | 2011 |
|
RU2500425C2 |
| MEDICATION FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2011 |
|
RU2536228C2 |
| METHOD OF ENDOTHELIAL DYSFUNCTION CORRECTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF ANGIOTENSIN II RECEPTOR C-TERMINAL FRAGMENT ANTIBODIES | 2011 |
|
RU2482546C2 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2541166C2 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF TUMOUR NECROSIS FACTOR ALPHA ANTIBODIES | 2011 |
|
RU2478233C2 |
| THERAPEUTIC AGENT FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2543331C2 |
| METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2011 |
|
RU2526149C2 |
